Protection from Toxic Shock

Abstract only A glycosphingolipid functions as an endogenous inhibitor of the TLR4-MD2 complex, which mediates the immune response to bacterially derived lipids. An excessive immune response to bacterial infection can lead to death due to massive tissue damage by the immune system. Kondo et al . fou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science signaling 2013-03, Vol.6 (268), p.ec73-ec73
1. Verfasser: Gough, Nancy R.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page ec73
container_issue 268
container_start_page ec73
container_title Science signaling
container_volume 6
creator Gough, Nancy R.
description Abstract only A glycosphingolipid functions as an endogenous inhibitor of the TLR4-MD2 complex, which mediates the immune response to bacterially derived lipids. An excessive immune response to bacterial infection can lead to death due to massive tissue damage by the immune system. Kondo et al . found that A4galt-deficient mice that cannot synthesize the globo-series glycosphingolipids, including Gb3 and Gb4, were more likely than wild-type mice to die in an assay of lipopolysaccharide (LPS)–induced lethal shock. Analysis of primary mouse vascular endothelial cell cultures from the A4galt-deficient mice showed that the cells exhibited an enhanced inflammatory response to LPS. Exposure of wild-type endothelial cells to LPS stimulated expression of A4galt and increased the cell surface abundance of Gb4. In vitro studies with recombinant tagged MD-2, a subunit of the Toll-like receptor 4 (TLR4) complex that binds and responds to LPS, showed that Gb4 bound directly to MD-2, and endogenous Gb4 was present with tagged MD-2 immunoprecipitated from an endothelial cell line. Binding studies with Gb4, LPS, and TLR4–MD-2 indicated that Gb4 functioned as a noncompetitive inhibitor of LPS by binding to the receptor, and molecular simulations suggested that Gb4 could make multiple interactions with amino acids in the receptor complex. Administration of Gb4 to mice reduced the lethality of injected LPS, and histological examination showed reduced lung and liver pathology compared with wild-type mice subjected to the same LPS dosing regimen. Thus, Gb4 appears to function as an endogenous inhibitor of the innate immune response by reducing activation of the TLR4–MD-2 complex by bacterial lipids. Y. Kondo, K. Ikeda, N. Tokuda, C. Nishitani, U. Ohto, S. Akashi-Takamura, Y. Ito, M. Uchikawa, Y. Kuroki, R. Taguchi, K. Miyake, Q. Zhang, K. Furukawa, K. Furukawa, TLF4–MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide. Proc. Natl. Acad. Sci. U.S.A. 110 , 4714–4719 (2013). [Abstract] [Full Text]
doi_str_mv 10.1126/scisignal.2004171
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1512332451</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1512332451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c145t-62e6ff3d1b0a8f77b96b30a01cb4b8c83c44db9d5a915be5e341aa754a3090a33</originalsourceid><addsrcrecordid>eNo9kM1KAzEYRYMoWKsPIG5m6Wbq9-VnMllK8Q8KCtZ1SDKJRqeTmkxB396WFlf3Lg5ncQi5RJgh0uamuFji-2D6GQXgKPGITFAxWSvk4nj3uaihlfKUnJXyCdAgpWpCrl5yGr0bYxqqkNOqWqaf6KrXj-S-zslJMH3xF4edkrf7u-X8sV48PzzNbxe127rHuqG-CYF1aMG0QUqrGsvAADrLbeta5jjvrOqEUSisF55xNEYKbhgoMIxNyfXeu87pe-PLqFexON_3ZvBpUzQKpIxRLnCL4h51OZWSfdDrHFcm_2oEvQuh_0PoQwj2BzOgUgk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1512332451</pqid></control><display><type>article</type><title>Protection from Toxic Shock</title><source>American Association for the Advancement of Science</source><creator>Gough, Nancy R.</creator><creatorcontrib>Gough, Nancy R.</creatorcontrib><description>Abstract only A glycosphingolipid functions as an endogenous inhibitor of the TLR4-MD2 complex, which mediates the immune response to bacterially derived lipids. An excessive immune response to bacterial infection can lead to death due to massive tissue damage by the immune system. Kondo et al . found that A4galt-deficient mice that cannot synthesize the globo-series glycosphingolipids, including Gb3 and Gb4, were more likely than wild-type mice to die in an assay of lipopolysaccharide (LPS)–induced lethal shock. Analysis of primary mouse vascular endothelial cell cultures from the A4galt-deficient mice showed that the cells exhibited an enhanced inflammatory response to LPS. Exposure of wild-type endothelial cells to LPS stimulated expression of A4galt and increased the cell surface abundance of Gb4. In vitro studies with recombinant tagged MD-2, a subunit of the Toll-like receptor 4 (TLR4) complex that binds and responds to LPS, showed that Gb4 bound directly to MD-2, and endogenous Gb4 was present with tagged MD-2 immunoprecipitated from an endothelial cell line. Binding studies with Gb4, LPS, and TLR4–MD-2 indicated that Gb4 functioned as a noncompetitive inhibitor of LPS by binding to the receptor, and molecular simulations suggested that Gb4 could make multiple interactions with amino acids in the receptor complex. Administration of Gb4 to mice reduced the lethality of injected LPS, and histological examination showed reduced lung and liver pathology compared with wild-type mice subjected to the same LPS dosing regimen. Thus, Gb4 appears to function as an endogenous inhibitor of the innate immune response by reducing activation of the TLR4–MD-2 complex by bacterial lipids. Y. Kondo, K. Ikeda, N. Tokuda, C. Nishitani, U. Ohto, S. Akashi-Takamura, Y. Ito, M. Uchikawa, Y. Kuroki, R. Taguchi, K. Miyake, Q. Zhang, K. Furukawa, K. Furukawa, TLF4–MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide. Proc. Natl. Acad. Sci. U.S.A. 110 , 4714–4719 (2013). [Abstract] [Full Text]</description><identifier>ISSN: 1945-0877</identifier><identifier>EISSN: 1937-9145</identifier><identifier>DOI: 10.1126/scisignal.2004171</identifier><language>eng</language><ispartof>Science signaling, 2013-03, Vol.6 (268), p.ec73-ec73</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2884,2885,27924,27925</link.rule.ids></links><search><creatorcontrib>Gough, Nancy R.</creatorcontrib><title>Protection from Toxic Shock</title><title>Science signaling</title><description>Abstract only A glycosphingolipid functions as an endogenous inhibitor of the TLR4-MD2 complex, which mediates the immune response to bacterially derived lipids. An excessive immune response to bacterial infection can lead to death due to massive tissue damage by the immune system. Kondo et al . found that A4galt-deficient mice that cannot synthesize the globo-series glycosphingolipids, including Gb3 and Gb4, were more likely than wild-type mice to die in an assay of lipopolysaccharide (LPS)–induced lethal shock. Analysis of primary mouse vascular endothelial cell cultures from the A4galt-deficient mice showed that the cells exhibited an enhanced inflammatory response to LPS. Exposure of wild-type endothelial cells to LPS stimulated expression of A4galt and increased the cell surface abundance of Gb4. In vitro studies with recombinant tagged MD-2, a subunit of the Toll-like receptor 4 (TLR4) complex that binds and responds to LPS, showed that Gb4 bound directly to MD-2, and endogenous Gb4 was present with tagged MD-2 immunoprecipitated from an endothelial cell line. Binding studies with Gb4, LPS, and TLR4–MD-2 indicated that Gb4 functioned as a noncompetitive inhibitor of LPS by binding to the receptor, and molecular simulations suggested that Gb4 could make multiple interactions with amino acids in the receptor complex. Administration of Gb4 to mice reduced the lethality of injected LPS, and histological examination showed reduced lung and liver pathology compared with wild-type mice subjected to the same LPS dosing regimen. Thus, Gb4 appears to function as an endogenous inhibitor of the innate immune response by reducing activation of the TLR4–MD-2 complex by bacterial lipids. Y. Kondo, K. Ikeda, N. Tokuda, C. Nishitani, U. Ohto, S. Akashi-Takamura, Y. Ito, M. Uchikawa, Y. Kuroki, R. Taguchi, K. Miyake, Q. Zhang, K. Furukawa, K. Furukawa, TLF4–MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide. Proc. Natl. Acad. Sci. U.S.A. 110 , 4714–4719 (2013). [Abstract] [Full Text]</description><issn>1945-0877</issn><issn>1937-9145</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNo9kM1KAzEYRYMoWKsPIG5m6Wbq9-VnMllK8Q8KCtZ1SDKJRqeTmkxB396WFlf3Lg5ncQi5RJgh0uamuFji-2D6GQXgKPGITFAxWSvk4nj3uaihlfKUnJXyCdAgpWpCrl5yGr0bYxqqkNOqWqaf6KrXj-S-zslJMH3xF4edkrf7u-X8sV48PzzNbxe127rHuqG-CYF1aMG0QUqrGsvAADrLbeta5jjvrOqEUSisF55xNEYKbhgoMIxNyfXeu87pe-PLqFexON_3ZvBpUzQKpIxRLnCL4h51OZWSfdDrHFcm_2oEvQuh_0PoQwj2BzOgUgk</recordid><startdate>20130326</startdate><enddate>20130326</enddate><creator>Gough, Nancy R.</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20130326</creationdate><title>Protection from Toxic Shock</title><author>Gough, Nancy R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c145t-62e6ff3d1b0a8f77b96b30a01cb4b8c83c44db9d5a915be5e341aa754a3090a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gough, Nancy R.</creatorcontrib><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Science signaling</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gough, Nancy R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protection from Toxic Shock</atitle><jtitle>Science signaling</jtitle><date>2013-03-26</date><risdate>2013</risdate><volume>6</volume><issue>268</issue><spage>ec73</spage><epage>ec73</epage><pages>ec73-ec73</pages><issn>1945-0877</issn><eissn>1937-9145</eissn><abstract>Abstract only A glycosphingolipid functions as an endogenous inhibitor of the TLR4-MD2 complex, which mediates the immune response to bacterially derived lipids. An excessive immune response to bacterial infection can lead to death due to massive tissue damage by the immune system. Kondo et al . found that A4galt-deficient mice that cannot synthesize the globo-series glycosphingolipids, including Gb3 and Gb4, were more likely than wild-type mice to die in an assay of lipopolysaccharide (LPS)–induced lethal shock. Analysis of primary mouse vascular endothelial cell cultures from the A4galt-deficient mice showed that the cells exhibited an enhanced inflammatory response to LPS. Exposure of wild-type endothelial cells to LPS stimulated expression of A4galt and increased the cell surface abundance of Gb4. In vitro studies with recombinant tagged MD-2, a subunit of the Toll-like receptor 4 (TLR4) complex that binds and responds to LPS, showed that Gb4 bound directly to MD-2, and endogenous Gb4 was present with tagged MD-2 immunoprecipitated from an endothelial cell line. Binding studies with Gb4, LPS, and TLR4–MD-2 indicated that Gb4 functioned as a noncompetitive inhibitor of LPS by binding to the receptor, and molecular simulations suggested that Gb4 could make multiple interactions with amino acids in the receptor complex. Administration of Gb4 to mice reduced the lethality of injected LPS, and histological examination showed reduced lung and liver pathology compared with wild-type mice subjected to the same LPS dosing regimen. Thus, Gb4 appears to function as an endogenous inhibitor of the innate immune response by reducing activation of the TLR4–MD-2 complex by bacterial lipids. Y. Kondo, K. Ikeda, N. Tokuda, C. Nishitani, U. Ohto, S. Akashi-Takamura, Y. Ito, M. Uchikawa, Y. Kuroki, R. Taguchi, K. Miyake, Q. Zhang, K. Furukawa, K. Furukawa, TLF4–MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide. Proc. Natl. Acad. Sci. U.S.A. 110 , 4714–4719 (2013). [Abstract] [Full Text]</abstract><doi>10.1126/scisignal.2004171</doi></addata></record>
fulltext fulltext
identifier ISSN: 1945-0877
ispartof Science signaling, 2013-03, Vol.6 (268), p.ec73-ec73
issn 1945-0877
1937-9145
language eng
recordid cdi_proquest_miscellaneous_1512332451
source American Association for the Advancement of Science
title Protection from Toxic Shock
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T15%3A21%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protection%20from%20Toxic%20Shock&rft.jtitle=Science%20signaling&rft.au=Gough,%20Nancy%20R.&rft.date=2013-03-26&rft.volume=6&rft.issue=268&rft.spage=ec73&rft.epage=ec73&rft.pages=ec73-ec73&rft.issn=1945-0877&rft.eissn=1937-9145&rft_id=info:doi/10.1126/scisignal.2004171&rft_dat=%3Cproquest_cross%3E1512332451%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1512332451&rft_id=info:pmid/&rfr_iscdi=true